These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36172919)

  • 21. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
    Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
    Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
    Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
    Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.
    Jin JJ; Liu YH; Si JM; Ni R; Wang J
    Int J Biochem Cell Biol; 2018 Feb; 95():113-120. PubMed ID: 29275213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
    Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
    Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial creatine kinase 1 regulates the cell cycle in non-small cell lung cancer via activation of cyclin-dependent kinase 4.
    Yang M; Wang X; Ye Z; Liu T; Meng Y; Duan Y; Yuan X; Yue X; Deng W; Liu RY
    Respir Res; 2023 Apr; 24(1):111. PubMed ID: 37061730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.
    Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Qian J; Gu J; Chang L; Ge D; Chu Y
    Br J Cancer; 2014 Jan; 110(2):353-62. PubMed ID: 24281003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS; Zheng YL; Zhao J; Chun X
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis.
    Azam SH; Porrello A; Harrison EB; Leslie PL; Liu X; Waugh TA; Belanger A; Mangala LS; Lopez-Berestein G; Wilson HL; McCann JV; Kim WY; Sood AK; Liu J; Dudley AC; Pecot CV
    Oncogene; 2019 Jun; 38(26):5191-5210. PubMed ID: 30918328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
    Dong Z; Liu H; Zhao G
    Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
    [No Abstract]   [Full Text] [Related]  

  • 35. miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
    Li S; Wang C; Yu X; Wu H; Hu J; Wang S; Ye Z
    Oncol Rep; 2017 Jan; 37(1):241-248. PubMed ID: 27878260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of synthetic small double-stranded RNA on the development of bladder cancer by activating P21 expression].
    Ge Q; Wang C; Chen Z; Zhang Q; Yang W; Ye Z
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(10):812-6. PubMed ID: 27055644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.
    Song Y; Dou H; Wang P; Zhao S; Wang T; Gong W; Zhao J; Li E; Tan R; Hou Y
    Cancer Biol Ther; 2014 Oct; 15(10):1423-30. PubMed ID: 25046358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linc00703 suppresses non-small cell lung cancer progression by modulating CyclinD1/CDK4 expression.
    Sun HB; Han XL; Zhong M; Yu DJ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6131-6138. PubMed ID: 32572878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.
    Lang B; Zhao S
    Oncol Rep; 2018 Jan; 39(1):71-80. PubMed ID: 29115564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [siRNA-mediated CDK6 knockdown suppresses nasopharyngeal carcinoma cell growth and cell cycle transition in vitro].
    Luo X; Xia Q; Qin J; Huang Y; Liu J; Wang Y; Wang H; Chen J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1071-4. PubMed ID: 25057088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.